Advertisement
Home Tags Drug Approvals

Tag: Drug Approvals

The Senza spinal cord stimulation system has been approved by the U.S. Food and Drug Administration to treat chronic intractable pain of the trunk and/or limbs

FDA: Senza Device Relieves Spinal Pain Without Paresthesia

0
Implanted device treats chronic back pain
Raplixa (human fibrin sealant) has been approved by the U.S. Food and Drug Administration to help control bleeding during surgery

FDA Approves Raplixa to Help Control Surgical Bleeding

0
Spray-dried fibrin sealant promotes clotting when other methods are 'ineffective or impractical'
Kybella (deoxycholic acid) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe submental fat.

FDA Approves Kybella for Reducing Submental Fat

0
Use for fat outside submental area not approved, not recommended
The first generic versions of the atypical antipsychotic drug Abilify (aripiprazole) have been approved by the U.S. Food and Drug Administration to treat schizophrenia or bipolar disorder.

FDA Approves First Generic Abilify

0
For treatment of bipolar disorder or schizophrenia
Corlanor (ivabradine) has been approved by the U.S. Food and Drug Administration to treat chronic heart failure

FDA Approves Corlanor for Chronic Heart Failure

0
Works by decreasing heart rate; first approved product in this drug class
The first U.S. generic version of Copaxone (glatiramer acetate injection) has been approved by the Food and Drug Administration to treat multiple sclerosis.

FDA: Generic Copaxone Approved for Multiple Sclerosis

0
FDA reviewed additional information to ensure generic is as safe and effective as brand-name drug
A new breath test (the Gastric Emptying Breath Test) has been approved by the U.S. Food and Drug Administration to aid in the diagnosis of gastroparesis.

FDA Approves New Test That Helps Diagnose Gastroparesis

0
Test is less invasive and can be administered in the physician's office
The Impella 2.5 System has been approved by the U.S. Food and Drug Administration to maintain stable heart function and blood circulation during high-risk cardiac operations

FDA Approves New Miniature Blood Pump System

0
Maintains circulation during high-risk percutaneous coronary intervention procedures
The U.S. Food and Drug Administration said Tuesday that use of the CoreValve "valve-in-valve" aortic replacement has been expanded to include people at extreme risk for serious complications from traditional open-heart surgery.

FDA Expands Approval for ‘Valve in Valve’ Aortic Replacement

0
Now includes people at risk for open-heart surgery complications
Anthrasil

FDA Approves New Treatment for Anthrax

0
FDA cites preparedness for intentional release of anthrax